Grupo Sanitario Ribera is moving fast to double its presence, snapping up hospitals and clinics across Spain and Portugal. The company’s leaders see consolidation as the only way forward for private healthcare.
Grupo Sanitario Ribera is wasting no time. President Víctor Sanz has set a clear target: double the group’s size in just four years. The plan is simple—buy up hospitals and clinics across Spain and Portugal. Sanz laid out this vision at the VII Simposio del Observatorio de la Sanidad, making it clear Ribera wants to lead the charge as Spain’s private healthcare sector starts to consolidate.
“We have a four-year growth plan and are open to opportunities in the Iberian Peninsula, Portugal included,” Sanz said. He stressed that every deal must fit Ribera’s growing network. The group’s recent purchase of a hospital group with sites in Benidorm and Denia shows this isn’t just talk. Ribera now operates in five countries. Sanz calls Spain’s healthcare market “overly atomized” and says it needs investment and scale. Ribera’s official statements confirm the HCB deal was its biggest private healthcare investment yet. The acquisition brought in two hospitals in Benidorm and Denia, three medical centers in Calpe, Moraira, and Albir, plus two diagnostic imaging centers in Alicante. More than 650 new employees joined the group.
The Spanish competition authority (CNMC) approved Ribera's acquisition of HCB on September 21, 2026, but imposed specific commitments to ensure compliance with competition rules.
Efficiency is Ribera’s main selling point. Sanz claims the group’s healthcare cost per covered person is 25% lower than the public system. He also points to shorter waiting lists for surgery and consultations, and higher patient satisfaction. Sanz credits this to tight management and a push to innovate, especially in sick leave protocols that help employees get back to work faster and lift national productivity.
Ribera isn’t just collecting hospitals for the sake of it. The group wants a network where doctors and staff can move easily between sites. Sanz says keeping talent is key. He revealed Ribera may offer doctors a stake in the company, following the model at its French affiliate Vivalto Santé, where medical professionals own 30% of shares across 50 hospitals. In Spain, Ribera’s staff turnover is just 4%. Sanz links this to the selective inclusion of doctors as shareholders. Leading Spanish business media reported that Ribera was picked as the exclusive candidate for the HCB deal in November 2025, and the sale closed about seven months later. Ribera says the integration will be gradual, keeping care consistent and using the combined network to fuel more European growth with Vivalto Santé.
Waiting lists are another battleground. Ribera focuses resources on the 4% of patients over 64 who use 80% of healthcare resources. Sanz says this approach prevents 41% of readmissions and 27% of consultations, freeing up operating rooms and making the system run smoother. This data-driven strategy is central to Ribera’s plan for a modern, sustainable healthcare group.
Prior to the HCB acquisition, Ribera already managed Ribera Imske Hospital, Vinalopó University Hospital, 14 primary care centers, three clinics, the Nefrosol dialysis center, Ribera Lab, and the Futurs technology company in the Valencian Community. The addition of HCB assets further strengthens Ribera's presence specifically in the coastal Alicante region, with the Denia hospital having officially opened in November 2022.
Spain’s healthcare sector is under pressure to modernize and cut waste. As recent coverage of technology adoption in Spanish hospitals shows, both public and private providers are scrambling to find new ways to deliver care and control costs.
Ribera’s bold expansion plan is shaking up the market. By betting on efficiency, talent retention, and smart acquisitions, the group is putting itself at the center of the next wave of healthcare in Spain and Portugal. Every move is measured, with a focus on building a network that makes sense on the map and for patients. If Ribera pulls this off, it could set a new bar for private healthcare in the region.
